Albemarle director receives stock grants

Collins Michelle T reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Collins Michelle T reported acquisition or exercise transactions in this Form 4 filing.

ALBEMARLE CORP director Michelle T. Collins reported stock-based compensation grants, not open-market trades. On July 1, 2026 she received 1,250 shares of common stock as an annual non-employee director award under the 2023 Directors Plan, scheduled to vest on July 1, 2027. She also received 2 additional shares representing dividends accrued on a prior award granted on February 26, 2026 that fully vested on July 1, 2026.

Insider Trade Summary

Grant/Award: 1,252 shares

Grant/Award 2 txns

Insider Collins Michelle T

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,250	$0.00	$0.00
Grant/Award	Common Stock	2	$0.00	$0.00

Holdings After Transaction: Common Stock — 1,577 shares (Direct)

Footnotes (2)

1. F1. Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.
2. F2. Represents dividends accrued on shares underlying an award granted on February 26, 2026, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

Key Figures

Director stock grant: 1,250 shares Dividend-equivalent shares: 2 shares Main grant vesting date: July 1, 2027 +2 more

5 metrics

Director stock grant 1,250 shares Annual non-employee director award on July 1, 2026

Dividend-equivalent shares 2 shares Dividends accrued on prior award, settled in stock

Main grant vesting date July 1, 2027 Vesting for 1,250-share director grant under 2023 plan

Prior award grant date February 26, 2026 Underlying award for which dividends accrued

Prior award vesting date July 1, 2026 Earlier award vested in full; dividends paid in shares

Key Terms

2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors, non-employee director stock compensation, dividends accrued, vested in full, +1 more

5 terms

2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors financial

"pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation"

non-employee director stock compensation financial

"Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Directors Plan"

dividends accrued financial

"Represents dividends accrued on shares underlying an award granted on February 26, 2026"

vested in full financial

"an award granted on February 26, 2026, that vested in full on July 1, 2026"

settle in shares of common stock financial

"which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Albemarle (ALB) director Michelle T. Collins report in this Form 4?

She reported stock compensation grants, not open-market trades. On July 1, 2026, she received 1,250 Albemarle common shares as a non-employee director award and 2 additional shares from accrued dividends, all under the company’s 2023 Directors Plan.

How many Albemarle (ALB) shares were granted to Michelle T. Collins as director compensation?

She received 1,250 shares as an annual non-employee director stock award. This grant was made under Albemarle’s 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors, reflecting routine equity-based board compensation rather than a market purchase.

When do Michelle T. Collins’s new Albemarle (ALB) director shares vest?

The 1,250-share director compensation grant is scheduled to vest on July 1, 2027. That vesting timing is set under Albemarle’s 2023 Directors Plan and ties the stock award to a longer-term service and retention horizon for the non-employee director.

What are the 2 additional Albemarle (ALB) shares disclosed in the filing?

The 2 shares represent dividends accrued on shares underlying a prior award granted February 26, 2026. That earlier award vested in full on July 1, 2026, and Albemarle elected to settle the accrued dividends in common stock under the 2023 Directors Plan.

Were Michelle T. Collins’s Albemarle (ALB) Form 4 transactions open-market purchases or sales?

No, the filing shows compensation-related acquisitions only. Both transactions carry code A for grants or awards, indicating shares were issued as director compensation and dividend equivalents, not bought or sold in the open market by the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 05:29 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Collins Michelle T

(Last) (First) (Middle)

4250 CONGRESS ST.

SUITE 900

(Street)

CHARLOTTE NORTH CAROLINA 28209

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		1,250(1)	A	$0	1,575	D
Common Stock	07/01/2026		A		2(2)	A	$0	1,577	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

2. Represents dividends accrued on shares underlying an award granted on February 26, 2026, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

Remarks:

	/s/ Corey E. Tanner, Attorney-in-fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)